TEVA PHARMACEUTICAL-SP ADR (TEVA) Stock Institutional Trading Activity


TEVA PHARMACEUTICAL-SP ADR (TEVA) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q3 2025), investors with some of the largest reported share count changes include Viking Global Investors, Renaissance Technologies LLC, Sound Shore Management, Sequoia Financial Advisors, and ARK Invest. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q2 2016Renaissance Technologies LLCBuy196,5001,387,763$69,707
Q2 2016Viking Global InvestorsSell-5,234,96727,736,655$1,393,212
Q2 2016Matrix Advisors Value FundBuy5,170235,472$11,828
Q1 2016Muhlenkamp & CoBuy205177,160$9,480
Q1 2016Renaissance Technologies LLCBuy658,7631,191,263$63,744
Q1 2016First Eagle U.S. ValueSell-2,455,9591,915,660$102,507
Q1 2016Viking Global InvestorsBuy7,927,84732,971,622$1,764,311
Q1 2016Matrix Advisors Value FundBuy3,353230,302$12,323
Q4 2015Renaissance Technologies LLCSell-2,346,263532,500$34,953
Q4 2015First Eagle U.S. ValueSell-95,3924,371,619$286,953
Q4 2015Viking Global InvestorsBuy16,171,12525,043,775$1,643,873
Q4 2015Matrix Advisors Value FundSell-121,350226,949$14,897
Q3 2015Muhlenkamp & CoBuy40176,955$9,991
Q3 2015Renaissance Technologies LLCBuy803,0002,878,763$162,535
Q3 2015First Eagle U.S. ValueBuy710,0134,467,011$252,207
Q3 2015Viking Global InvestorsBuy8,644,0508,872,650$500,950
Q3 2015Matrix Advisors Value FundSell-14,559348,299$19,665
Q2 2015Muhlenkamp & CoBuy205176,915$10,456
Q2 2015Renaissance Technologies LLCBuy736,8002,075,763$122,678
Q2 2015First Eagle U.S. ValueSell-448,4833,756,998$222,039
Q2 2015Matrix Advisors Value FundSell-5,245362,858$21,445
Q1 2015Muhlenkamp & CoBuy325176,710$11,009
Q1 2015Viking Global InvestorsBuy228,600228,600$14,242
Q1 2015Renaissance Technologies LLCBuy374,3001,338,963$83,417
Q1 2015First Eagle U.S. ValueBuy1,757,1714,205,481$262,002
Q1 2015Matrix Advisors Value FundBuy4,389368,103$22,933
Q4 2014Muhlenkamp & CoSell-470176,385$10,144
Q4 2014Renaissance Technologies LLCBuy699,800964,663$55,478
Q4 2014First Eagle U.S. ValueBuy1,027,7302,448,310$140,803
Q4 2014Matrix Advisors Value FundBuy252363,714$20,917

Frequently asked questions about TEVA activity

  • Which institutional owners are buying TEVA?

    Institutional owners buying TEVA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in TEVA activity?

    "Buy" means an investor increased their reported position in TEVA compared to the prior reporting period. This reflects growing exposure to TEVA PHARMACEUTICAL-SP ADR (TEVA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in TEVA increasing?

    Institutional interest in TEVA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.